Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pyruvate Kinase M2 Role in Cardiovascular Repair.

Cells·2025
Same author

Phosphoserine aminotransferase 1 promotes serine synthesis pathway and cardiac repair after myocardial infarction.

Theranostics·2025
Same author

Podoplanin-positive cell-derived small extracellular vesicles contribute to cardiac amyloidosis after myocardial infarction.

Cell reports·2025
Same author

GPC3-mediated metabolic rewiring of diabetic mesenchymal stromal cells enhances their cardioprotective functions via PKM2 activation.

iScience·2024
Same author

Podoplanin Positive Cell-derived Extracellular Vesicles Contribute to Cardiac Amyloidosis After Myocardial Infarction.

bioRxiv : the preprint server for biology·2024
Same author

Tipifarnib Reduces Extracellular Vesicles and Protects From Heart Failure.

Circulation research·2024

Related Experiment Video

Updated: May 15, 2025

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

6.0K

Inhalable exosomes to target cardiac repair.

Ajit Magadum1,2

  • 1Aging and Cardiovascular Discovery Center (ACDC), Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.

Extracellular Vesicles and Circulating Nucleic Acids
|April 10, 2025
PubMed
Summary

Stem Cell-derived Exosome Nebulization Therapy (SCENT) offers a novel, non-invasive way to repair hearts after myocardial infarction using inhaled exosomes. This cell-free regenerative therapy shows promise in animal models for improving cardiac function and reducing injury.

Keywords:
CD36Inhalationcardiovascular diseaseexosomesnon-invasive delivery

More Related Videos

Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

614
Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

8.2K

Related Experiment Videos

Last Updated: May 15, 2025

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

6.0K
Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

614
Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

8.2K

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Nanotechnology

Background:

  • Myocardial infarction (MI) leads to significant cardiac damage and functional decline.
  • Current treatments for MI have limitations in promoting true cardiac repair.
  • Cell-free therapies offer potential advantages over traditional cell-based approaches.

Purpose of the Study:

  • To introduce Stem Cell-derived Exosome Nebulization Therapy (SCENT) as a novel regenerative strategy for cardiac repair post-MI.
  • To evaluate the efficacy of SCENT in promoting cardiac function and reducing injury.
  • To assess the translational potential of SCENT in preclinical animal models.

Main Methods:

  • Development of Stem Cell-derived Exosome Nebulization Therapy (SCENT).
  • Delivery of lung spheroid cell-derived exosomes via inhalation.
  • Assessment of cardiac function and injury markers in small and large animal models of myocardial infarction.

Main Results:

  • SCENT administration significantly improved cardiac function after myocardial infarction.
  • The therapy led to a reduction in cardiac injury.
  • Positive outcomes were observed in both small and large animal models, indicating translational potential.

Conclusions:

  • Stem Cell-derived Exosome Nebulization Therapy (SCENT) is a promising non-invasive, cell-free approach for cardiac regeneration.
  • Inhalable exosomes represent a viable strategy for treating myocardial infarction.
  • SCENT demonstrates significant translational potential for future clinical applications.